Lorcaserin
- Generic Name
- Lorcaserin
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
- Conditions
- Interventions
- First Posted Date
- 2017-05-08
- Last Posted Date
- 2020-11-12
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 32
- Registration Number
- NCT03143855
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Gene-by-Stress Interactions in Intervention Studies Significance
- Conditions
- Interventions
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Duke University
- Target Recruit Count
- 7
- Registration Number
- NCT03011645
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Lorcaserin in the Treatment of Cocaine Use Disorder
- Conditions
- Interventions
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 272
- Registration Number
- NCT03007394
- Locations
- 🇺🇸
Pacific Treatment and Research Center, La Jolla, California, United States
🇺🇸Pharmacology Research Institute, Newport Beach, California, United States
🇺🇸George Washington University, Washington, District of Columbia, United States
Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
- First Posted Date
- 2016-10-13
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 17
- Registration Number
- NCT02932215
- Locations
- 🇺🇸
Columbia Substance Treatment and Research Service, New York, New York, United States
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
- Conditions
- Interventions
- First Posted Date
- 2016-09-20
- Last Posted Date
- 2019-05-07
- Lead Sponsor
- Duke University
- Target Recruit Count
- 97
- Registration Number
- NCT02906644
- Locations
- 🇺🇸
Duke Center for Smoking Cessation, Durham, North Carolina, United States
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 71
- Registration Number
- NCT02796144
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
🇺🇸Carolina Behavioral Care, Hillsborough, North Carolina, United States
🇺🇸New York State Psychiatric Institute (NYSPI), Columbia University, New York, New York, United States
Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
- Conditions
- Interventions
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 29
- Registration Number
- NCT02537873
- Locations
- 🇺🇸
Virginia Commonwealth University, Institute for Drug and Alcohol Studies, Richmond, Virginia, United States
Evaluating Muscle Weakness Improvement With Lorcaserin in ICU
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 5
- Registration Number
- NCT02523690
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Addressing Post Cessation Weight Gain
- Conditions
- Interventions
- First Posted Date
- 2015-04-09
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 84
- Registration Number
- NCT02412631
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
- Conditions
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 20
- Registration Number
- NCT02393599
- Locations
- 🇺🇸
Vince Associates Clinical Research, Inc., Overland Park, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.